SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " risk " 4,042 found 🔀 AI-powered Shuffle
Why where you live matters for heart health — even in childhood - Baylor College of Medicine Blog Network
Evidence links environmental exposures to early cardiovascular risk, disproportionately impacting marginalized communities like AI/AN youth.
What Happens to Your Liver When You Drink Green Tea Every Day
What does green tea do for your liver? Learn how it may affect fat buildup, inflammation, and liver enzymes, plus risks and benefits.
Bayer wins in US court, but at what cost to public health?
A landmark US Supreme Court ruling protects Bayer from thousands of lawsuits linked to its Roundup weedkiller. Plaintiffs alleged the German agrochemical giant failed to warn users about potential cancer risks.
Parasite Affecting 1 in 3 People Is a Serious Risk to Human Health, Scientists Warn
More needs to be done.
Serious statin side effects on muscles are extremely rare, new research confirms
Scientists created a new tool to help doctors predict a patient’s risk of severe muscle problems from taking a statin.
Monkey Business: Wild rhesus macaque spotted at Mount Dora hotel
A wild rhesus macaque was spotted at the historic Lakeside Inn in Mount Dora, Florida, spending about 45 minutes roaming the property and attracting attention from guests and staff. The hotel and local businesses responded with humorous, monkey-themed social media content, engaging the community. Wildlife officials cautioned the public not to approach or feed wild monkeys due to potential health risks and encouraged reporting sightings to authorities. The monkey has not returned to the hotel but has been seen elsewhere in downtown Mount Dora.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
5 states targeting Medicaid behavioral health enrollment amid fraud concerns
At least five states have taken steps in 2026 to restrict new Medicaid behavioral health provider enrollments as stakeholders seek to curb fraud, waste and abuse while strengthening oversight of high-risk services. The developments come as the Trump administration aims to crack down on healthcare fraud. On June 25, the Justice Department charged 455 people, […]
Consumer Discretionary Stocks Drawing Institutional Rotation Into Live Entertainment Leaders
With the Federal Reserve hinting at a pause in rate hikes, stubborn inflation still in the background, and several large companies surprising on earnings, consumer discretionary stocks are back in focus for investors weighing risk and opportunity. This article looks at how that mix of easier policy signals, solid corporate reports, and ongoing geopolitical and supply chain issues could affect larger U.S. consumer-focused companies. It will walk through 3 stocks from a curated screener that...
Two NC lawmakers, a Democrat and a Republican, push Congress to delay SNAP changes
Above the federal penalty threshold, NC could owe $140M a year, putting at risk a program that helps over 1.2 million North Carolinians.
Gillings-supported center helps public health teams prioritize infectious disease risks, from measles to the World Cup - UNC Gillings School of Global Public Health
June 25, 2026 When public health workers prepare for infectious disease threats, the question is rarely whether risk exists. It is where to focus first.
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
Their Family Business Went From Bankruptcy to a $4 Billion Snack Empire: Inside Jack Link’s Wild Entrepreneurial Ride
Meat, risk, and NASCAR — here's how Jack Link's CEO Troy Link has grown his family business into a global phenomenon.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
Living with a cat: the mental health impact scientists are only now discovering - Futura-Sciences
A Surprising Connection Between Cats and Schizophrenia? An Australian study has revealed an unexpected link between cat ownership and the risk of developing schizophrenia. Researchers analyzed 17 studies conducted over 44 years, spanning 11 different countries. Their conclusion? Living with a cat could actually double your risk of developing schizophrenia-related...
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
This Doctor Can Change the Color of Your Eyes. Should He?
Francis Ferrari, a French ophthalmologist, invented a controversial procedure that can change eye color. People from around the world are willing to take the risk.
20 everyday habits that affect your heart health
Cardiovascular disease is the world's leading cause of death — and most of its risk factors are behavioral, not genetic. These are the daily habits that matter most
Is This How Nike Is Shaking Up Its China Business?
BNP analyst Laurent Vasilescu considers the risk for Nike if a media report is accurate about a plan to change in distribution in China.
In failing to address Pride Night controversy, Giants' Buster Posey risks tarnishing his once untouchable legacy
An Evening of Hope: The Center for Youth Mental Health Hosts its Annual Benefit Dinner
The annual benefit dinner for the Center for Youth Mental Health at NewYork-Presbyterian was hosted by Anna Wintour, Mariska Hargitay, Dr. Zandy Forbes, Dr. Brian G. Donley, and Kim Richter Shirley and Jon Shirley.
5 foods that contain both protein and fiber
With these sweet-spot foods you get both the protein perks, like muscle maintenance, and the fiber perks, like improved gut health and reduced risks of chronic conditions, all in one bite.
France confirms first Ebola case in doctor returning from DR Congo
The patient is in isolation, following strict biosafety protocols to prevent risk of spread in France.
Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
By Dennis Thompson HealthDay ReporterWEDNESDAY, June 24, 2026 (HealthDay News) — Want to give your baby the best start in life? Then tend to your heart health, both prior to and during pregnancy, a new study says. Expectant mothers in worse heart health are more likely to have children who suffer ...
Elon Musk’s trillionaire status at risk after drops in SpaceX and Tesla’s shares
Rolling coverage of the latest economic and financial news
Diabetes patients in Gaza face survival battle amid war shortages
Insulin and equipment shortages in Gaza pose fatal risks, leading to critical health complications.
UK heatwave: Red extreme heat warning to take effect
The warning, which means there could be a risk to life, will be in force in parts of England and Wales from 09:00.
Private equity’s move into youth sports brings some truths home
Investments create benefits but also lead to higher costs and risk of inequality
Invasive ticks confirmed in Connecticut, pose health risks
Two invasive tick species, the Lone Star tick and the Asian longhorned tick, have been confirmed in Connecticut.
Want to feel happier at work? Take a five-minute walk
Sitting for prolonged periods is associated with health complications – but you can counteract the risks of a sedentary life.
How top CMOs from Gap, Duolingo are rewriting the marketing playbook
Top marketers argue that embracing authenticity, moving fast, and creative risks are the only ways to survive in a fragmented digital world.
Vending machine with risk reduction and healthcare products installed in Linn
A vending machine containing overdose prevention supplies and personal health and hygiene products has been installed in Linn.
Retatrutide: What To Know About Online Sales, Safety Risks and More
Retatrutide: What To Know About Online Sales, Safety Risks and More
Israeli Soldiers Fatally Shoot 2 People in Southern Lebanon, Health Officials Say
The shooting came a day after Israeli troops began operating under new orders intended to reduce the risk of flare-ups in its conflict with Iran-backed Hezbollah militants.
CDC’s chief blocked a covid vaccine study. Now it’s in a top medical journal.
The study found that the vaccine reduced the risk of emergency department visits and hospitalizations among healthy adults by about half last winter.
Explainer: The health risks of extreme heat
The world is baking under extreme heat, with Europe, Asia and parts of the U.S. all dealing with scorching temperatures.
E-bike injuries rising among kids as Corewell Health doctors warn parents about speed, safety risks
E-bikes have exploded in popularity among adults, teens, and even some tweens. But as more people are riding them, injuries have increased, too.
United Nations: business can’t build economic resilience from the sidelines
As geopolitical risk rises and the $4 trillion SDG financing gap widens, blended finance will only scale if companies help design systems.
Want a younger brain? Exercise in your 40s may help.
Even if you’ve never worked out, starting in middle age — even with brisk walks — can have a bigger impact on your brain than you think.
Outrage rescued an important ocean research program. Crucial ones remain at risk.
Senators saved a network of ocean sensors from "supreme stupidity." But other cutting-edge efforts are running out of funding, too.
Romania’s Political Turmoil Deepens After PM Hopeful Loses Vote
Romania’s prime minister nominee failed to win parliamentary approval for his proposed cabinet, prolonging a political deadlock that risks stalling key reforms for crucial European Union recovery funding.
Meta AI training data leak exposed employee activity across company
Meta's AI Model Capability Initiative faces scrutiny after a data leak exposes internal security risks, sparking employee concerns.
How This Common Painkiller Is Stopping Cancer From Spreading, Scientists Reveal - Futura-Sciences
Guess Who? The Painkiller Hiding a Secret Weapon Riddle: it’s in countless family medicine cabinets. It’s the go-to when fever or pain strikes. For more than half a century, scientists have known about its anticancer properties. Some even believe it might lower the risk of metastases—those are the little troublemakers...
'Fresh brisket on the board': Buc-ee's is cooking up big business on its first day in Goodyear
ABC15's Jordan Bontke takes a look inside Buc-ee's five hours after its grand opening, along with its legendary brisket.
Fentrice Driskell lands trove of labor, environmental group endorsements
Driskell earned support from one of the state's largest labor unions.
Anyone can fake a scientific image with AI, tricking even academic journals – and undermining trust in science
Several scientific fields rely on visual evidence to illustrate their claims. Inaccurate AI-generated images put the credibility of science at risk.
‘Daily cuts… infections’: India’s e-waste workers face toxic health risks
As digital consumption grows and e-waste mounts, burden of managing that waste falls on workers with little protection.
Infringement risks of AIGC in entertainment industry (Part 2)
From talent contracts to AI tool whitelists, AIGC compliance is no longer just risk control but a core issue for financing, listing and digital asset operations
Long-term health risks of e-cigarettes after smoking cessation
Nature Medicine - Real‑world evidence from a nationwide cohort suggests that using electronic cigarettes after smoking cessation may attenuate the benefits of quitting in reducing lung cancer...
Penicillin Allergy Labels May Pose Health Risks in Kids
Children with a penicillin allergy label have higher rates of methicillin-resistant Staphylococcus aureus colonization, surgical site infections, and all-cause mortality than those without the label.
The Pulse: Women's Health is Having a Reckoning - The Longevity Gap is Where it Starts
Welcome to our new series The Pulse, covering everything you need to know about the age of intelligent health.From ovarian aging and maternal health to cardiovascular and dementia risk, HLTH USA 2026 is programming the women’s health conversations medicine has been too slow to have.While women live longer than men, they spend 25% longer in poor health. The healthspan gap, between how long women live and how long they live in good health, is the defining focus of the next frontier in women’s health. “Diminished healthspan ...
Ken Griffin fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Billionaire fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Billionaire fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Rep. Jason Crow says he's worried "Americans are at risk" with Bill Pulte as acting DNI
France restricts public drinking and outdoor sports as heat wave bakes parts of Europe
France is in the grips of a severe heat wave, leading to canceled trains, concerts and sports events. Authorities have banned public drinking in “red alert” zones to reduce risks.
France restricts public drinking and outdoor sports as heat wave bakes parts of Europe
The Eiffel Tower and other Paris venues set up misting stations to cool crowds, among a raft of measures introduced by authorities to minimize risks. Tourists in Rome dunked in fountains. Spain’s Basque Country canceled some sports and cultural events.
What are the smoke and health risks from the Boyle Heights fire?
More bad air is expected around the Boyle Heights warehouses that has been burning since Wednesday.
Is hearing loss an Alzheimer’s warning sign? Research shows new risk factors
The number of people living with Alzheimer’s disease is expected to double by 2060. New research is shedding light on warning signs and risk factors that could signal cognitive decline ahead.
There are higher colon cancer rates among people of Cajun descent. Here’s what doctors are doing to help.
Learn about the significance of colonoscopies in detecting and preventing colon cancer, especially in high-risk populations like the Cajun community in Louisiana. Early screenings can save lives and improve outcomes.
‘Build Vice City’: the GTA 6 scam that’s hitting Grand Theft Auto fans
Bank details at risk as criminals use AI to create fake sites and emails offering pre-release beta test version
Major review finds vaping likely causes lung and oral cancer
Researchers have concluded that nicotine vapes are likely to cause lung and oral cancers, based on evidence ranging from human biomarkers to animal and laboratory studies. The findings challenge the idea that vaping is a harmless alternative to smoking and suggest health risks may be emerging much sooner than many expected.
‘A child goes to bed and doesn’t wake up’: the families left in shock after the sudden death of their healthy children
Sudden cardiac arrest is statistically rare but among the leading causes of death for children and young people. And families often have no idea of the risk until it’s too late
New research casts doubt on cannabis benefits, cites mental health risks
Fox News senior medical analyst Dr. Marc Siegel discusses new research on modern marijuana’s high THC potency and increased mental health risks on ‘Fox & Friends Weekend.’
World Cup Health And Security Risks Will Grow In The Knockout Phase
This is the largest and most complex World Cup ever, with three host countries and 48 teams. It will place unprecedented challenges on medical and security staff
One of My Favorite Xbox Studios Is Being Shut Down – What Xbox Games Are Now Cancelled or Shutting Down Because of the Closures?
Xbox is in the process of a reset, with multiple studios reportedly in danger of closure. What does this mean for the games they're making? We look at which Xbox games could be cancelled, and which are safe.
Around the Empire: You gotta always protect the McNuggets!
Jazz playing a risky game; Righty catcher, bullpen top trade priorities; Strzelecki opts out of minor league deal
Ukraine's war robots are surging into the kill zone
Business Insider went inside a Ukrainian factory building ground robots for deadly missions soldiers can no longer risk.
How to stay cool and limit health risks during Oregon summer heat
Oregon Health Authority says young children and older adults are just a couple of groups of people that face a higher risk of heat related illness.
Easy money or risky business? What can Hong Kong do as prediction markets boom?
Despite official warnings ahead of World Cup, Polymarket and Kalshi remain popular with residents who bet on everything from politics to weather.
Taking supplements every day? You might be doing more harm than good
While many of us take supplements regularly, there are some risks people may not be aware of.
The ‘risky business’ behind Puget Sound transportation planning
(The Center Square) - Puget Sound Regional Council's recent update to their 2050 regional transportation plan failed to account for Sound Transit's recent changes to ST3 deferring certain light rail
Chichester tyre business banned over 'fire risks'
Twyford Recycling's operating permit has been removed with immediate effect.
Unpatchable 'usbliter8' Exploit Breaks Apple A12 and A13 SecureROM Boot Chain
Paradigm Shift’s usbliter8 exploit targets Apple A12 and A13 SecureROM via USB DFU mode, creating an unpatchable hardware risk.
Amazon Will Make Billions on Prime Day. For Small Businesses, the Math Doesn't Always Add Up
Prime Day boosts Amazon’s gains while putting intense pressure on sellers to cut prices, absorb costs, and take on most of the risk.
Researchers uncover an unpatchable security flaw affecting several iPhone generations
All devices running A12, A13, S4 and S5 chips are at risk. Researchers at Paradigm Shift published an extensive report that details the inherent security...
Scientists are uncovering how common viruses may quietly increase cancer risk
Everyday viral infections may be quietly reshaping the body’s network of molecules that support cells and tissues in ways that can raise cancer risk over time
Can Better Sleep Lower Dementia Risk? What the Science Says
Poor sleep may raise your Alzheimer's risk by as much as 44%. Here's what researchers know about sleep, brain health, and what you can do tonight.
Balancing benefit and risk: Nisha Vora on the science of pharmacovigilance
As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly.
‘If it doesn’t work out, I’m blaming JD’: Vance’s risky gambit on Iran peace efforts
As the Trump administration neared a breakthrough in its negotiations with Iran, Vice President JD Vance jumped at the chance to be the face of a peace agreement designed to end months of unpopular war.
IOM Conducts Over 1 Million Health Screenings, Scales Up Ebola Response
Geneva/Nairobi 19 June 2026 – The International Organization for Migration (IOM) has conducted more than one million health screenings at borders and along key cross-border routes and travel corridors across Ebola-affected and at-risk countries as it scales up its efforts to support the control of an outbreak that has spread across eastern Democratic Republic of the Congo (DRC) and Uganda.
Warner says Iran war is driving up Virginia costs, warns Trump is playing politics with intelligence post
Senator points to higher fertilizer and energy prices, touts housing bill and warns of risks to elections and kids online
The unwanted return of tetanus; why soccer makes people so happy; breast cancer in men; plus other stories with Vanderbilt Health sources
Women’s Health interviewed Kathryn Edwards, MD, Sarah H. Sell and Cornelius Vanderbilt Professor of Pediatrics, for a story about her JAMA Viewpoint article on tetanus making a comeback. Women’s Health interviewed Colin Armstrong, PhD, Assistant Professor of Clinical Psychiatry and Behavioral Sciences and Assistant Professor of Physical Medicine and Rehabilitation, for a story tied to the World Cup about why soccer makes people so happy. An NBC News story about the announcement by “X-Men” actor and former wrestler Tyler Mane that he has breast cancer quotes Ben Ho Park, MD, director of the Vanderbilt-Ingram Cancer Center. The story focuses on how a prominent man with breast cancer may help remove some stigma from a cancer that is rare in males. Prevention magazine interviewed Caitlyn Mooney, MD, Assistant Professor, Department of Orthopaedic Surgery, for a story about a BMJ study that suggests 90 to 120 minutes per week of strength training may lower the risk of death. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Women’s Health (norovirus is more common this summer); SFGate (measles in San Francisco just before the World Cup crowds); Travel + Leisure (how to avoid getting sick on a cruise); and Fox News (mosquito-borne diseases). Reporter Liz DeSantis from WKRN News 2 aired a story on the rehab unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt. Kat Hedden, PT, DPT, PCS, CBIS, Acute Pediatric Physical Therapy Clinical Team Lead and Mary McLanahan, MD, Assistant Professor of Physical Medicine and Rehabilitation were interviewed, as well as the family of patient Will Terry. Reporter Nikki Hauser from WTVF News Channel 5 interviewed Graden Knapp, Gaming and Technology Specialist at Monroe Carell Jr. Children’s Hospital at Vanderbilt about his 3-D wheelchair project. Tennesseanreporter Sandy Mazza covered the announcement of the latest Leadership Nashville class, which includes Jane Freedman, MD, Deputy CEO, and Chief Health Systems Office for Vanderbilt Health; and also the announcement of the latest Leadership Tennessee cohort, which includes Jeff Upperman, MD, Surgeon in Chief at Monroe Carroll Jr Children’s Hospital at Vanderbilt.
What if there is no one to farm? Scientists reveal a hidden risk to future food security
The cause of future food shortages may not be a lack of farmland, but a shortage of agricultural workers. Amid low birth rates and rural decline, a joint international research team from KAIST has developed ...
AMC Entertainment Stock Advances As Retail Traders Fuel Volatility Following Latest Corporate Equity Capital Raise
AMC Entertainment stock jumps 9.8% on record May attendance, CEO insider buying, and improving U.S. box office — but balance sheet risks remain elevated.
Trump Iran framework gambles on diplomacy despite warning Tehran will 'lie and cheat'
Trump administration's Iran framework offers immediate oil sanctions waivers while postponing key nuclear questions, a gamble officials say carries risks.
Michigan’s aging brains need more protection, poll shows
Lifestyle changes can reduce risk of Alzheimer’s disease and other forms of dementia but a poll shows many Michiganders over 50 don’t know about or do them.
Michigan’s aging brains need more protection, poll shows
Lifestyle changes can reduce risk of Alzheimer’s disease and other forms of dementia but a poll shows many Michiganders over 50 don’t know about or do them.
Hegseth announces 6-month review of American forces in Europe, blasts NATO allies for putting troops 'at risk'
War Secretary Pete Hegseth announces six-month review of U.S. force deployment in Europe, pressing NATO allies to take primary responsibility for defense.
The pressure to have baby boys can harm African mothers’ health
In Congo and other parts of Africa, some women are having baby after baby under cultural pressure to produce a male heir, even risking their health.
The pressure for baby boys affects Africa's mothers and their health
In Congo and other parts of Africa, some women are having baby after baby under cultural pressure to produce a male heir, even risking their health.
Health department reports new travel-related dengue case on Oahu
Health officials said that the expected risk of local transmission is low.
Nationwide nursing-home picture comes into focus with new analysis
Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.
Researchers found 8 common food additives linked to high blood pressure and heart disease
A major study of more than 112,000 people found that eating foods containing common preservatives may be linked to a higher risk of high blood pressure and heart-related diseases. Researchers tracked participants for up to eight years and discovered that people consuming the highest amounts of certain preservatives had significantly greater risks of hypertension, heart attack, stroke, and other cardiovascular problems.
Tech Founder’s Downfall in Indonesia Shows Rising Business Risks
The trial of one of Southeast Asia’s most successful entrepreneurs is adding to concern about governance under President Prabowo Subianto.